Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient
试验速览
- 阶段
- 不适用
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- cardiovascular event, bleeding event,and thrombosis
研究概览
简要总结
The purpose of this study is to determine whether aspirin resistance has impact on cardiovascular event in dialysis patient.
详细描述
Dialysis patient inevitably suffered from uremic bleeding although improvement of dialysis care in the past decades. Physicians used to check bleeding time as a surrogate marker for uremic bleeding. However, bleeding time isn't accurate and as well known, is poorly correlated with clinical bleeding such as surgical bleeding. Platelet function assay (PFA) is a newly developed method to measure platelet aggregation in vitro and is validated in many sorts of platelet disorders. Recently, PFA was also used to evaluate aspirin responsiveness in patients who had taken aspirin. Our study is aim to investigate uremic thrombocytopathy via PFA of dialysis patient in Taiwan. Furthermore, we will study aspirin resistance in dialysis patient.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 20 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •dialysis >3 months
- •Hb>10 g/dl & Plt > 10000
排除标准
- •using medication which interfere PFA except aspirin
- •terminal disease such as malignancy
- •active vasculitis
结局指标
主要结局
cardiovascular event, bleeding event,and thrombosis
时间窗: 1 year
次要结局
未报告次要终点
